Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.25
-0.54 (-7.95%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Pulmonx Statistics

Total Valuation

Pulmonx has a market cap or net worth of $244.70 million. The enterprise value is $213.88 million.

Market Cap 244.70M
Enterprise Value 213.88M

Important Dates

The last earnings date was Wednesday, October 30, 2024, after market close.

Earnings Date Oct 30, 2024
Ex-Dividend Date n/a

Share Statistics

Pulmonx has 39.15 million shares outstanding. The number of shares has increased by 2.88% in one year.

Shares Outstanding 39.15M
Shares Change (YoY) +2.88%
Shares Change (QoQ) +0.86%
Owned by Insiders (%) 4.26%
Owned by Institutions (%) 89.46%
Float 37.48M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.32
Forward PS 2.88
PB Ratio 2.84
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.70
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.70, with a Debt / Equity ratio of 0.59.

Current Ratio 7.70
Quick Ratio 6.53
Debt / Equity 0.59
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -16.30

Financial Efficiency

Return on equity (ROE) is -51.99% and return on invested capital (ROIC) is -22.90%.

Return on Equity (ROE) -51.99%
Return on Assets (ROA) -20.65%
Return on Capital (ROIC) -22.90%
Revenue Per Employee $284,237
Profits Per Employee -$204,685
Employee Count 279
Asset Turnover 0.45
Inventory Turnover 1.24

Taxes

In the past 12 months, Pulmonx has paid $710,000 in taxes.

Income Tax 710,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -20.79% in the last 52 weeks. The beta is 0.64, so Pulmonx's price volatility has been lower than the market average.

Beta (5Y) 0.64
52-Week Price Change -20.79%
50-Day Moving Average 7.26
200-Day Moving Average 8.39
Relative Strength Index (RSI) 40.82
Average Volume (20 Days) 209,043

Short Selling Information

The latest short interest is 1.78 million, so 4.55% of the outstanding shares have been sold short.

Short Interest 1.78M
Short Previous Month 1.68M
Short % of Shares Out 4.55%
Short % of Float 4.75%
Short Ratio (days to cover) 8.38

Income Statement

In the last 12 months, Pulmonx had revenue of $79.30 million and -$57.11 million in losses. Loss per share was -$1.47.

Revenue 79.30M
Gross Profit 58.81M
Operating Income -58.21M
Pretax Income -57.29M
Net Income -57.11M
EBITDA -54.32M
EBIT -58.21M
Loss Per Share -$1.47
Full Income Statement

Balance Sheet

The company has $107.78 million in cash and $55.81 million in debt, giving a net cash position of $51.97 million or $1.33 per share.

Cash & Cash Equivalents 107.78M
Total Debt 55.81M
Net Cash 51.97M
Net Cash Per Share $1.33
Equity (Book Value) 93.93M
Book Value Per Share 2.39
Working Capital 122.63M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 74.16%, with operating and profit margins of -73.40% and -72.01%.

Gross Margin 74.16%
Operating Margin -73.40%
Pretax Margin -71.12%
Profit Margin -72.01%
EBITDA Margin -68.50%
EBIT Margin -73.40%
FCF Margin -46.14%

Dividends & Yields

Pulmonx does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2.88%
Shareholder Yield -2.88%
Earnings Yield -21.48%
FCF Yield n/a

Analyst Forecast

The average price target for Pulmonx is $13.83, which is 121.28% higher than the current price. The consensus rating is "Strong Buy".

Price Target $13.83
Price Target Difference 121.28%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (5Y) 20.87%
EPS Growth Forecast (5Y) -16.87%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 4